What is it about?
This study introduces a new class useful in the traetment of autoimmune disorders like rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus erythematosus, sarcoidosis, focal segmental glomerulosclerosis, Crohn's disease, Behcet's Disease, pemphigus, and ulcerative colitis.
The following have contributed to this page: mustafa ghanadian
PDF generated on 17-Oct-2017
In partnership with: